Updated incarnation of my hypothesis abstract:
NEURAL SENSITIVITY IN THE PATHOGENESIS OF ME/CFS (abbreviated title)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) a debilitating condition of unknown aetiology, classified as a disease of the central nervous system by the World Health Organisation. In recent years the disease has been linked to neural sensitisation specifically and in this speculative article, I describe a new hypothesis for the etiopathogenesis of ME/CFS in the slightly broader context of neural sensitivity.
The discussion primarily touches on neurogenic sources of sensitivity and irritation, peripheral-central sensitisation mechanisms, and the theorised role of sensitisation feedback loops in subsequent, purportedly increasingly noxious, afferent input.
The article further discusses how, in a significant subset of patients, symptom aggravation and illness complication has recently been hypothetically explained in terms of a exaggerated ‘sickness behaviour’ that can occur when sensory ganglia or paraganglia are infected. Pathological disarray linked to pernicious and persistent nature of the pathogens commonly involved, and associated humoral immune responses, in the context of elevated neural sensitivity, may account for this exaggeration.
Adverse neuroexcitatory and neuroimmune themes are discussed in relation to neuroendocrine, mitochondrial, metabolic and autonomic function, as well as theoretical predisposing risk factors, the effects of which can elevate central sensitivity. The neural sensitivity disease model I present contends that there are important common genetic, epigenetic, and in many instances behavioural and environmental, factors involved in the precipitation, complication and modulation, of the fundamental disease pathophysiology.
Drawing upon relevant findings from the neurology literature I present a rudimentary model for the etiopathogenesis of ME/CFS centred on neural (hyper)sensitivity. Sensitising propensities theoretically lead to excitotoxicity, neuroinflammation, and possibly also central sensitisation and sensory gating irregularities, and enhance the potential for pathogen activation and adverse neuroimmune responses including autoimmunity and the central initiation of ‘sickness behaviour’.
This neuroimmunological model may explain why only a small proportion of the general population infected with pathogens commonly associated with ME/CFS go on to develop the condition. The model provides a platform, and suggestions for, future exploration and testing of component hypothetical pathological links, as well as insights into the efficacy of existing treatment strategies and ideas for the development of fresh approaches.
Keywords
ME/CFS; Myalgic encephalomyelitis; M.E; Chronic fatigue syndrome; CFS; Neural sensitivity; Central sensitisation, Microglial activation, Neuroexcitation; Excitotoxicity; Neuroinflammation; Neuroimmune; Etiopathogenesis; Pathophysiology;
© John H Wolfe (2013)